Tech Company Financing Transactions
Hemoshear Funding Round
On 5/7/2014, Hemoshear secured $8.7 million in Series C funding from private investors.
Transaction Overview
Company Name
Announced On
5/7/2014
Transaction Type
Venture Equity
Amount
$8,700,000
Round
Series C
Investors
Proceeds Purpose
This offering will support a number of investments to grow the Company. HemoShear will soon relocate its operations to state-of-the-art facilities in Charlottesville, Virginia. The new facility will address current needs and support future expansion. In addition, this new capital will allow the Company to accelerate development of human disease systems, including those for tumors and rare diseases, as well as recruit scientific and bioinformatics expertise.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
501 Locust Ave. 301
Charlottesville, VA 22902
USA
Charlottesville, VA 22902
USA
Phone
Website
Email Address
Overview
Unlocking human disease biology at a level not possible until now. THINK HUMAN.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim Powers
Chief Financial Officer
Aric Holsinger
Chief Medical Officer
Gerry Cox
Chief Operating Officer
Brian Wamhoff
Chief Scientific Officer
Brian Johns
VP - Bus. Development
Michael Innes
VP - Marketing
Susan Klees
VP - Operations
Michael Simmers
VP - Operations
Mavis Waller
VP - Regulatory Affairs
Mark Hayes
Browse more venture capital transactions:
Prev: 5/7/2014: Maxta venture capital transaction
Next: 5/7/2014: BlueStacks venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs